Labrys Biologics was a clinical-stage biopharmaceutical company founded in 2012 and headquartered in San Mateo, California, developing monoclonal antibody therapeutics targeting calcitonin gene-related peptide (CGRP) for the prevention of chronic and episodic migraine. - View it on GitHub